In this video, Gaurav Narula, MD, Tata Memorial Center, Mumbai, India, briefly discusses challenges with access to CAR-T therapy from a global perspective, which was an international session that took place at this year’s meeting. Dr Narula also highlights the high cost of CAR-T cells, and ongoing efforts to develop these agents for patients in India. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.